BREANNA YAGGY: Open Payments
NPI 1871328104 · BRANSON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,375 in 93 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $554 · 2025 $2,375
Food & beverage: $2,276Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 26 | $737 |
| Regeneron Healthcare Solutions, Inc. | 12 | $341 |
| GENZYME CORPORATION | 11 | $242 |
| Inspire Medical Systems, Inc. | 2 | $183 |
| Actelion Pharmaceuticals US, Inc. | 5 | $137 |
| Viatris Specialty LLC | 5 | $90 |
| GlaxoSmithKline, LLC. | 5 | $89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $73 |
| Grifols USA, LLC | 3 | $72 |
| Baxter Healthcare | 3 | $64 |
Products named: DUPIXENT, AIRSUPRA, INSPIRE, BREZTRI, FASENRA, TEZSPIRE, UPTRAVI, YUPELRI.
Industry payments across MO — which companies pay providers there.
